Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical Outcome
Open Access
- 12 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (4), 558-566
- https://doi.org/10.1093/infdis/jiu088
Abstract
Background. Ebola hemorrhagic fever (EHF) outbreaks occur sporadically in Africa and result in high rates of death. The 2000–2001 outbreak of Sudan virus–associated EHF in the Gulu district of Uganda led to 425 cases, of which 216 were laboratory confirmed, making it the largest EHF outbreak on record. Serum specimens from this outbreak had been preserved in liquid nitrogen from the time of collection and were available for analysis. Methods. Available samples were tested using a series of multiplex assays to measure the concentrations of 55 biomarkers. The data were analyzed to identify statistically significant associations between the tested biomarkers and hemorrhagic manifestations, viremia, and/or death. Results. Death, hemorrhage, and viremia were independently associated with elevated levels of several chemokines and cytokines. Death and hemorrhage were associated with elevated thrombomodulin and ferritin levels. Hemorrhage was also associated with elevated levels of soluble intracellular adhesion molecule. Viremia was independently associated with elevated levels of tissue factor and tissue plasminogen activator. Finally, samples from nonfatal cases had higher levels of sCD40L. Conclusions. These novel associations provide a better understanding of EHF pathophysiology and a starting point for researching new potential targets for therapeutic interventions.Keywords
This publication has 33 references indexed in Scilit:
- Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Bundibugyo, Uganda, 2007–2008PLOS ONE, 2012
- Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, UgandaEmerging Infectious Diseases, 2010
- Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte ApoptosisPLoS Neglected Tropical Diseases, 2010
- Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic FeverThe Journal of Infectious Diseases, 2007
- Blood Chemistry Measurements andd‐Dimer Levels Associated with Fatal and Nonfatal Outcomes in Humans Infected with Sudan Ebola VirusThe Journal of Infectious Diseases, 2007
- Sequence‐Based Human Leukocyte Antigen–B Typing of Patients Infected with Ebola Virus in Uganda in 2000: Identification of Alleles Associated with Fatal and Nonfatal Disease OutcomesThe Journal of Infectious Diseases, 2007
- Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide LevelsJournal of Virology, 2004
- Human Macrophage C-Type Lectin Specific for Galactose andN-Acetylgalactosamine Promotes Filovirus EntryJournal of Virology, 2004
- Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamilyImmunology Letters, 2002
- Ferritin levels in pediatric HIV‐1 infectionActa Paediatrica, 1994